Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbohydrate-protein conjugate vaccines.

G Ada1, D Isaacs

  • 1John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. gordon.ada@anu.edu.au

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|February 18, 2003
PubMed
Summary

Polysaccharide-protein conjugate vaccines significantly enhance protection against bacterial infections, especially in young children. This breakthrough offers hope for global disease control, with high success rates demonstrated for several pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergy in the elderly: A case note review of referrals to an adult allergy clinic.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

Overview of vaccines.

Methods in molecular medicine·2011
Same author

Oral nystatin prophylaxis and neonatal fungal infections.

Archives of disease in childhood. Fetal and neonatal edition·2009
Same author

Increased mortality among patients sustaining hip fractures requiring surgery in a district general hospital.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2009
Same author

The seven ages of man and woman (or "Sex and the CT").

Archives of disease in childhood·2008
Same author

Neonatal infections in Asia.

Archives of disease in childhood. Fetal and neonatal edition·2008

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • Polysaccharide vaccines offer limited protection, particularly in children.
  • Conjugating polysaccharides to proteins enhances immunogenicity, a concept known since 1931.

Purpose of the Study:

  • To review the development and efficacy of polysaccharide-protein conjugate vaccines.
  • To highlight their impact on reducing childhood mortality and morbidity.

Main Methods:

  • Clinical testing of polysaccharide-protein conjugate vaccines against pathogenic bacteria.
  • Immunization strategies involving early infant vaccination and boosters.

Main Results:

  • Remarkably high success rates (>95%) in protecting children from diseases caused by Haemophilus influenza type b.

Related Experiment Videos

  • Encouraging results for conjugate vaccines against Streptococcus pneumoniae, Neisseria meningiditis, and Salmonella typhi.

    • Conclusions:

    • Polysaccharide-protein conjugate vaccines represent a major advancement in vaccinology.
    • These vaccines show potential for global disease control, particularly in vulnerable pediatric populations.